Cargando…
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)
For many decades immune thrombocytopenia (ITP) was managed using therapies which had not undergone randomised clinical trials and included corticosteroids, immune suppression or splenectomy. These older therapies are associated with an increase in morbidity and mortality. These empirical therapies h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989102/ https://www.ncbi.nlm.nih.gov/pubmed/35391624 http://dx.doi.org/10.1007/s12325-022-02133-1 |